These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3871312)

  • 1. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Dowling-Zimmerman S; Pickar D; Boronow J; Morihisa JM; van Kammen DP; Carpenter W; Kessler R
    Am J Psychiatry; 1985 Jan; 142(1):78-81. PubMed ID: 3871312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.
    Volkow ND; Wolf AP; Van Gelder P; Brodie JD; Overall JE; Cancro R; Gomez-Mont F
    Am J Psychiatry; 1987 Feb; 144(2):151-8. PubMed ID: 3492931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frontal glucose utilization in chronic schizophrenia: a replication study.
    Wolkin A; Angrist B; Wolf A; Brodie JD; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Am J Psychiatry; 1988 Feb; 145(2):251-3. PubMed ID: 3257653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures.
    Losonczy MF; Song IS; Mohs RC; Small NA; Davidson M; Johns CA; Davis KL
    Am J Psychiatry; 1986 Aug; 143(8):976-81. PubMed ID: 3524278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricle-brain ratio and alogia in 19 young patients with chronic negative and positive schizophrenia.
    Moscarelli M; Cesana BM; Ciussani S; Novati NC; Cazzullo CL
    Am J Psychiatry; 1989 Feb; 146(2):257-8. PubMed ID: 2912270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenic dementia. Clinical and computed axial tomography correlates.
    Lawson WB; Waldman IN; Weinberger DR
    J Nerv Ment Dis; 1988 Apr; 176(4):207-12. PubMed ID: 3351499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased temporal lobe glucose use in chronic schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
    Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect.
    Shelton RC; Karson CN; Doran AR; Pickar D; Bigelow LB; Weinberger DR
    Am J Psychiatry; 1988 Feb; 145(2):154-63. PubMed ID: 3277448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
    Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M
    J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of very poor outcome schizophrenia.
    Keefe RS; Mohs RC; Losonczy MF; Davidson M; Silverman JM; Kendler KS; Horvath TB; Nora R; Davis KL
    Am J Psychiatry; 1987 Jul; 144(7):889-95. PubMed ID: 3605400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low cerebellar metabolism in medicated patients with chronic schizophrenia.
    Volkow ND; Levy A; Brodie JD; Wolf AP; Cancro R; Van Gelder P; Henn F
    Am J Psychiatry; 1992 May; 149(5):686-8. PubMed ID: 1575261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain organization in schizophrenia.
    Volkow ND; Brodie JD; Wolf AP; Gomez-Mont F; Cancro R; Van Gelder P; Russell JA; Overall J
    J Cereb Blood Flow Metab; 1986 Aug; 6(4):441-6. PubMed ID: 3488322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms and hypofrontality in chronic schizophrenia.
    Wolkin A; Sanfilipo M; Wolf AP; Angrist B; Brodie JD; Rotrosen J
    Arch Gen Psychiatry; 1992 Dec; 49(12):959-65. PubMed ID: 1360200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenic symptoms and deterioration. Relation to computed tomographic findings.
    Pandurangi AK; Bilder RM; Rieder RO; Mukherjee S; Hamer RM
    J Nerv Ment Dis; 1988 Apr; 176(4):200-6. PubMed ID: 3351498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.